{ "x402Version": 2, "id": 39205, "slug": "39205", "resource": "https://api.magentlab.com/api/calc/doac_score", "description": "Aggarwal 2023 DOAC Score (Circulation Table 2) for AF on DOACs: age 65-69 2 / 70-74 3 / 75-79 4 / >=80 5 (<65 0); CrCl/eGFR 30-60 inclusive 1, <30 2; underweight caller BMI <18.5 flag 1; stroke/TIA/embolism 1; diabetes 1; hypertension 1; antiplatelet none 0, aspirin 2, dual 3; NSAID 1; bleeding history 3; liver disease 2. Score min(raw, 10). Bands 0-3 very_low, 4-5 low, 6-7 moderate, 8-9 high, 10 very_high. Not HAS-BLED. Not DOAC dosing. Not warfarin.", "type": "http", "serviceName": "magent", "resourceType": "Agent Service", "accepts": [ { "scheme": "exact", "network": "eip155:8453", "payTo": "0x836Be278f1739fB4308091cD1852F7971Bc19Ee2", "asset": "0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913", "amount": "5000", "amountUsd": 0.005, "maxTimeoutSeconds": 600 } ], "outputSchema": { "properties": { "example": { "type": "object" }, "type": { "type": "string" } }, "required": [ "type" ], "type": "object" }, "extensions": { "bazaar": { "info": { "iconUrl": "https://api.magentlab.com/favicon.ico", "input": { "body": { "items": [ { "age": 65, "antiplatelet": "none", "bleeding_history": false, "crcl_or_egfr_ml_min": 70, "diabetes": false, "hypertension": false, "liver_disease": false, "nsaid_use": false, "stroke_tia_embolism_history": false, "underweight": false }, { "age": 65, "antiplatelet": "none", "bleeding_history": false, "crcl_or_egfr_ml_min": 70, "diabetes": false, "hypertension": false, "liver_disease": false, "nsaid_use": false, "stroke_tia_embolism_history": false, "underweight": false } ] }, "method": "POST", "type": "http" }, "output": { "example": { "count": 2, "items": [ { "age_years": 65, "antiplatelet": "none", "band": "very_low", "citation": { "authors": "Aggarwal R, Ruff CT, Virdone S, Perreault S, Kakkar AK, Palazzolo MG, Dorais M, Kayani G, Singer DE, Secemsky E, Piccini J, Tahir UA, Shen C, Yeh RW", "doi": "10.1161/CIRCULATIONAHA.123.064556", "id": "aggarwal-2023", "pmid": "37621213", "source": "Circulation. 2023;148(12):936-946", "title": "Development and Validation of the DOAC Score: A Novel Bleeding Risk Prediction Tool for Patients With Atrial Fibrillation on Direct-Acting Oral Anticoagulants" }, "components": [ { "factor": "age", "points": 2, "present": true, "value": 65 }, { "factor": "crcl_or_egfr", "points": 0, "present": false, "value": 70 }, { "factor": "underweight", "points": 0, "present": false }, { "factor": "stroke_tia_embolism_history", "points": 0, "present": false }, { "factor": "diabetes", "points": 0, "present": false }, { "factor": "hypertension", "points": 0, "present": false }, { "factor": "antiplatelet", "points": 0, "present": false, "value": "none" }, { "factor": "nsaid_use", "points": 0, "present": false }, { "factor": "bleeding_history", "points": 0, "present": false }, { "factor": "liver_disease", "points": 0, "present": false } ], "crcl_or_egfr_ml_min": 70, "disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.", "formula": "doac_score", "formula_expression": "DOAC Score (Aggarwal 2023 Circulation Table 2) = age (65-69 2, 70-74 3, 75-79 4, >=80 5; <65 0) + crcl_or_egfr_ml_min (30-60 inclusive 1, <30 2, >60 0) + underweight 1 + stroke_tia_embolism_history 1 + diabetes 1 + hypertension 1 + antiplatelet (none 0, aspirin 2, dual 3) + nsaid_use 1 + bleeding_history 3 + liver_disease 2; score = min(raw_sum, 10); bands 0-3 very_low, 4-5 low, 6-7 moderate, 8-9 high, 10 very_high; not HAS-BLED; not DOAC dosing; not warfarin", "max_score": 10, "score": 2, "uncapped_sum": 2 }, { "age_years": 65, "antiplatelet": "none", "band": "very_low", "citation": { "authors": "Aggarwal R, Ruff CT, Virdone S, Perreault S, Kakkar AK, Palazzolo MG, Dorais M, Kayani G, Singer DE, Secemsky E, Piccini J, Tahir UA, Shen C, Yeh RW", "doi": "10.1161/CIRCULATIONAHA.123.064556", "id": "aggarwal-2023", "pmid": "37621213", "source": "Circulation. 2023;148(12):936-946", "title": "Development and Validation of the DOAC Score: A Novel Bleeding Risk Prediction Tool for Patients With Atrial Fibrillation on Direct-Acting Oral Anticoagulants" }, "components": [ { "factor": "age", "points": 2, "present": true, "value": 65 }, { "factor": "crcl_or_egfr", "points": 0, "present": false, "value": 70 }, { "factor": "underweight", "points": 0, "present": false }, { "factor": "stroke_tia_embolism_history", "points": 0, "present": false }, { "factor": "diabetes", "points": 0, "present": false }, { "factor": "hypertension", "points": 0, "present": false }, { "factor": "antiplatelet", "points": 0, "present": false, "value": "none" }, { "factor": "nsaid_use", "points": 0, "present": false }, { "factor": "bleeding_history", "points": 0, "present": false }, { "factor": "liver_disease", "points": 0, "present": false } ], "crcl_or_egfr_ml_min": 70, "disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.", "formula": "doac_score", "formula_expression": "DOAC Score (Aggarwal 2023 Circulation Table 2) = age (65-69 2, 70-74 3, 75-79 4, >=80 5; <65 0) + crcl_or_egfr_ml_min (30-60 inclusive 1, <30 2, >60 0) + underweight 1 + stroke_tia_embolism_history 1 + diabetes 1 + hypertension 1 + antiplatelet (none 0, aspirin 2, dual 3) + nsaid_use 1 + bleeding_history 3 + liver_disease 2; score = min(raw_sum, 10); bands 0-3 very_low, 4-5 low, 6-7 moderate, 8-9 high, 10 very_high; not HAS-BLED; not DOAC dosing; not warfarin", "max_score": 10, "score": 2, "uncapped_sum": 2 } ], "path": "/api/calc/doac_score" }, "type": "json" } }, "schema": { "$schema": "https://json-schema.org/draft/2020-12/schema", "properties": { "input": { "additionalProperties": false, "properties": { "body": { "additionalProperties": false, "properties": { "items": { "items": { "properties": { "age": { "description": "Age in years (18-120). Table 2: 65-69 scores 2; 70-74 scores 3; 75-79 scores 4; ≥80 scores 5; age <65 scores 0 and is accepted.", "type": "integer" }, "antiplatelet": { "description": "Antiplatelet use: none (0), aspirin (2), or dual (aspirin + P2Y12; 3). Table 2.", "enum": [ "none", "aspirin", "dual" ], "type": "string" }, "bleeding_history": { "description": "Bleeding history as assigned by the caller. true or false. Scores 3.", "type": "boolean" }, "crcl_or_egfr_ml_min": { "description": "Creatinine clearance or eGFR in mL/min (5-200). Table 2: 30-60 inclusive scores 1; <30 scores 2; >60 scores 0. Exactly 30 and exactly 60 score 1.", "type": "number" }, "diabetes": { "description": "Diabetes as assigned by the caller. true or false. Scores 1.", "type": "boolean" }, "hypertension": { "description": "Hypertension as assigned by the caller. true or false. Scores 1.", "type": "boolean" }, "liver_disease": { "description": "Liver disease as assigned by the caller (Table 2 footnote: AST, ALT, or ALP ≥3× ULN, ALP ≥2× ULN, or cirrhosis). true or false. Scores 2. magent does not assay labs or assign Child-Pugh.", "type": "boolean" }, "nsaid_use": { "description": "NSAID use as assigned by the caller. true or false. Scores 1.", "type": "boolean" }, "stroke_tia_embolism_history": { "description": "History of stroke, TIA, or embolism as assigned by the caller. true or false. Scores 1.", "type": "boolean" }, "underweight": { "description": "Caller-assigned BMI <18.5 kg/m² (Table 2 underweight). true or false. Scores 1. magent does not compute BMI.", "type": "boolean" } }, "required": [ "age", "crcl_or_egfr_ml_min", "underweight", "stroke_tia_embolism_history", "diabetes", "hypertension", "antiplatelet", "nsaid_use", "bleeding_history", "liver_disease" ], "type": "object" }, "maxItems": 25, "minItems": 1, "type": "array" } }, "required": [ "items" ], "type": "object" }, "headers": { "additionalProperties": { "type": "string" }, "type": "object" }, "method": { "const": "POST", "type": "string" }, "type": { "const": "http", "type": "string" } }, "required": [ "type", "method" ], "type": "object" }, "output": { "properties": { "example": { "type": "object" }, "type": { "type": "string" } }, "required": [ "type" ], "type": "object" } }, "required": [ "input" ], "type": "object" } } }, "tags": [ "doac-score", "bleeding", "afib", "doac", "score", "bazaar" ], "sourceHost": "api.magentlab.com", "lastUpdated": "2026-10-13T02:51:00.508Z", "quality": { "calls30d": 5, "uniquePayers30d": 2, "lastCalledAt": "2026-10-13T02:51:00.359Z" }, "metadata": { "serviceName": "magent", "extensions": { "bazaar": { "info": { "iconUrl": "https://api.magentlab.com/favicon.ico", "input": { "body": { "items": [ { "age": 65, "antiplatelet": "none", "bleeding_history": false, "crcl_or_egfr_ml_min": 70, "diabetes": false, "hypertension": false, "liver_disease": false, "nsaid_use": false, "stroke_tia_embolism_history": false, "underweight": false }, { "age": 65, "antiplatelet": "none", "bleeding_history": false, "crcl_or_egfr_ml_min": 70, "diabetes": false, "hypertension": false, "liver_disease": false, "nsaid_use": false, "stroke_tia_embolism_history": false, "underweight": false } ] }, "method": "POST", "type": "http" }, "output": { "example": { "count": 2, "items": [ { "age_years": 65, "antiplatelet": "none", "band": "very_low", "citation": { "authors": "Aggarwal R, Ruff CT, Virdone S, Perreault S, Kakkar AK, Palazzolo MG, Dorais M, Kayani G, Singer DE, Secemsky E, Piccini J, Tahir UA, Shen C, Yeh RW", "doi": "10.1161/CIRCULATIONAHA.123.064556", "id": "aggarwal-2023", "pmid": "37621213", "source": "Circulation. 2023;148(12):936-946", "title": "Development and Validation of the DOAC Score: A Novel Bleeding Risk Prediction Tool for Patients With Atrial Fibrillation on Direct-Acting Oral Anticoagulants" }, "components": [ { "factor": "age", "points": 2, "present": true, "value": 65 }, { "factor": "crcl_or_egfr", "points": 0, "present": false, "value": 70 }, { "factor": "underweight", "points": 0, "present": false }, { "factor": "stroke_tia_embolism_history", "points": 0, "present": false }, { "factor": "diabetes", "points": 0, "present": false }, { "factor": "hypertension", "points": 0, "present": false }, { "factor": "antiplatelet", "points": 0, "present": false, "value": "none" }, { "factor": "nsaid_use", "points": 0, "present": false }, { "factor": "bleeding_history", "points": 0, "present": false }, { "factor": "liver_disease", "points": 0, "present": false } ], "crcl_or_egfr_ml_min": 70, "disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.", "formula": "doac_score", "formula_expression": "DOAC Score (Aggarwal 2023 Circulation Table 2) = age (65-69 2, 70-74 3, 75-79 4, >=80 5; <65 0) + crcl_or_egfr_ml_min (30-60 inclusive 1, <30 2, >60 0) + underweight 1 + stroke_tia_embolism_history 1 + diabetes 1 + hypertension 1 + antiplatelet (none 0, aspirin 2, dual 3) + nsaid_use 1 + bleeding_history 3 + liver_disease 2; score = min(raw_sum, 10); bands 0-3 very_low, 4-5 low, 6-7 moderate, 8-9 high, 10 very_high; not HAS-BLED; not DOAC dosing; not warfarin", "max_score": 10, "score": 2, "uncapped_sum": 2 }, { "age_years": 65, "antiplatelet": "none", "band": "very_low", "citation": { "authors": "Aggarwal R, Ruff CT, Virdone S, Perreault S, Kakkar AK, Palazzolo MG, Dorais M, Kayani G, Singer DE, Secemsky E, Piccini J, Tahir UA, Shen C, Yeh RW", "doi": "10.1161/CIRCULATIONAHA.123.064556", "id": "aggarwal-2023", "pmid": "37621213", "source": "Circulation. 2023;148(12):936-946", "title": "Development and Validation of the DOAC Score: A Novel Bleeding Risk Prediction Tool for Patients With Atrial Fibrillation on Direct-Acting Oral Anticoagulants" }, "components": [ { "factor": "age", "points": 2, "present": true, "value": 65 }, { "factor": "crcl_or_egfr", "points": 0, "present": false, "value": 70 }, { "factor": "underweight", "points": 0, "present": false }, { "factor": "stroke_tia_embolism_history", "points": 0, "present": false }, { "factor": "diabetes", "points": 0, "present": false }, { "factor": "hypertension", "points": 0, "present": false }, { "factor": "antiplatelet", "points": 0, "present": false, "value": "none" }, { "factor": "nsaid_use", "points": 0, "present": false }, { "factor": "bleeding_history", "points": 0, "present": false }, { "factor": "liver_disease", "points": 0, "present": false } ], "crcl_or_egfr_ml_min": 70, "disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.", "formula": "doac_score", "formula_expression": "DOAC Score (Aggarwal 2023 Circulation Table 2) = age (65-69 2, 70-74 3, 75-79 4, >=80 5; <65 0) + crcl_or_egfr_ml_min (30-60 inclusive 1, <30 2, >60 0) + underweight 1 + stroke_tia_embolism_history 1 + diabetes 1 + hypertension 1 + antiplatelet (none 0, aspirin 2, dual 3) + nsaid_use 1 + bleeding_history 3 + liver_disease 2; score = min(raw_sum, 10); bands 0-3 very_low, 4-5 low, 6-7 moderate, 8-9 high, 10 very_high; not HAS-BLED; not DOAC dosing; not warfarin", "max_score": 10, "score": 2, "uncapped_sum": 2 } ], "path": "/api/calc/doac_score" }, "type": "json" } }, "schema": { "$schema": "https://json-schema.org/draft/2020-12/schema", "properties": { "input": { "additionalProperties": false, "properties": { "body": { "additionalProperties": false, "properties": { "items": { "items": { "properties": { "age": { "description": "Age in years (18-120). Table 2: 65-69 scores 2; 70-74 scores 3; 75-79 scores 4; ≥80 scores 5; age <65 scores 0 and is accepted.", "type": "integer" }, "antiplatelet": { "description": "Antiplatelet use: none (0), aspirin (2), or dual (aspirin + P2Y12; 3). Table 2.", "enum": [ "none", "aspirin", "dual" ], "type": "string" }, "bleeding_history": { "description": "Bleeding history as assigned by the caller. true or false. Scores 3.", "type": "boolean" }, "crcl_or_egfr_ml_min": { "description": "Creatinine clearance or eGFR in mL/min (5-200). Table 2: 30-60 inclusive scores 1; <30 scores 2; >60 scores 0. Exactly 30 and exactly 60 score 1.", "type": "number" }, "diabetes": { "description": "Diabetes as assigned by the caller. true or false. Scores 1.", "type": "boolean" }, "hypertension": { "description": "Hypertension as assigned by the caller. true or false. Scores 1.", "type": "boolean" }, "liver_disease": { "description": "Liver disease as assigned by the caller (Table 2 footnote: AST, ALT, or ALP ≥3× ULN, ALP ≥2× ULN, or cirrhosis). true or false. Scores 2. magent does not assay labs or assign Child-Pugh.", "type": "boolean" }, "nsaid_use": { "description": "NSAID use as assigned by the caller. true or false. Scores 1.", "type": "boolean" }, "stroke_tia_embolism_history": { "description": "History of stroke, TIA, or embolism as assigned by the caller. true or false. Scores 1.", "type": "boolean" }, "underweight": { "description": "Caller-assigned BMI <18.5 kg/m² (Table 2 underweight). true or false. Scores 1. magent does not compute BMI.", "type": "boolean" } }, "required": [ "age", "crcl_or_egfr_ml_min", "underweight", "stroke_tia_embolism_history", "diabetes", "hypertension", "antiplatelet", "nsaid_use", "bleeding_history", "liver_disease" ], "type": "object" }, "maxItems": 25, "minItems": 1, "type": "array" } }, "required": [ "items" ], "type": "object" }, "headers": { "additionalProperties": { "type": "string" }, "type": "object" }, "method": { "const": "POST", "type": "string" }, "type": { "const": "http", "type": "string" } }, "required": [ "type", "method" ], "type": "object" }, "output": { "properties": { "example": { "type": "object" }, "type": { "type": "string" } }, "required": [ "type" ], "type": "object" } }, "required": [ "input" ], "type": "object" } } } }, "liveness": { "reliability": null }, "verified": false, "featured": false, "provider": { "host": "api.magentlab.com", "manifest_name": "api.magentlab.com", "source": "cdp-mirror", "source_manifest_url": "https://api.cdp.coinbase.com/platform/v2/x402/discovery/resources", "submitted_at": "2026-10-14T01:15:01.050Z" }, "exampleResponse": { "example": {}, "type": "string" } }